Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

Latest News

Elon Musk Continues To Defend Ketamine

Read More

MAPS and the City of Denver Make Psychedelic History

In a groundbreaking move, the Multidisciplinary Association for Psychedelic Studies (MAPS) has joined forces with Denver, marking a historic collaboration aimed at revolutionizing emergency response to psychedelic crises. This partnership brings forth a comprehensive training program dedicated to psychedelic crisis assessment and intervention for the city’s first responders. Initiated by the Denver Psilocybin Mushroom Policy…

Investments in Studying Solid Tumors Could Increase in 2024

What does this mean for the psychedelic industry? In the ever-evolving landscape of biopharmaceutical investments, a notable shift is occurring, drawing eyes toward neuroscience and oncology, particularly in the realms of psychedelics and cancer research. The year 2024 is shaping up to be a pivotal moment, continuing the momentum gained in previous years. The convergence…

Survey Shows Public’s Growing Acceptance of Magic Mushrooms

In a landmark study on the “moral status” of psilocybin, nearly 9 out of 10 Americans have voiced their approval for the controlled, licensed use of this psychedelic to treat psychiatric conditions or to promote general well-being. This consensus emerges from a study that showcases an overwhelming bipartisan support for supervised psilocybin use, both for…

Cleveland Clinic Launches Nationwide Clinical Trial for Magic Mushrooms

At the forefront of medical innovation, the Cleveland Clinic is pioneering a study that revisits the potential of psychedelics, substances traditionally linked with recreational use, as a beacon of hope for mental health treatment. This ambitious research revolves around psilocybin, the primary psychoactive component in magic mushrooms, and its capacity to address various mental health…